Holdings
Empery Asset Management, LP
As of Sep 30, 2026, Empery Asset Management, LP reported 19 positions worth US$78.4M. Largest: X4 Pharmaceuticals, Inc., Empery Digital Inc. and Outlook Therapeutics, Inc. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| X4 Pharmaceuticals, Inc. | 9.73M | US$28.2M | +2.79M | Sep 30, 2026 |
| Empery Digital Inc. | 4.83M | US$14.5M | +1.9M | Sep 30, 2026 |
| Outlook Therapeutics, Inc. | 21.2M | US$12.2M | new | Sep 30, 2026 |
| NervGen Pharma Corp. | 3.31M | US$6.32M | −691K | Sep 30, 2026 |
| CleanCore Solutions Inc. | 20M | US$2.6M | new | Sep 30, 2026 |
| Pyxis Oncology, Inc. | 1M | US$2.33M | new | Sep 30, 2026 |
| Cellectar Biosciences, Inc. | 955K | US$1.76M | +766K | Sep 30, 2026 |
| Amylyx Pharmaceuticals, Inc. | 60,000 | US$1.75M | new | Sep 30, 2026 |
| Dyadic International, Inc. | 3.35M | US$1.49M | new | Sep 30, 2026 |
| Tenaya Therapeutics, Inc. | 2.13M | US$1.28M | −1.73M | Sep 30, 2026 |